475 Avenue Louise1050 Brussels (Belgium)+32 (0) 22 457 105
Rbla. Catalunya 60 Pral. 2ª08007 Barcelona (Spain)+34 932 721 320
Linkedin
info@careventures.eu
Corus’ presence at the Dental Tribune’s IDS 2023
CENTOGENE is partnering with IQVIA to improve health outcomes for rare disease patients
Corus expands into the UK with the integration of Byrnes Dental Laboratory
Corus grows in Spain with the acquisition of two laboratories in Seville and Madrid
Centogene reaches 12,500 patient milestone in world’s largest observational study on Parkinson’s disease genetics
Corus expands into Scandinavia with the integration of Nordentic, the region’s largest player in dental technology
Centogene and Agios expand partnership for clinical development of PYRUKYND® (mitapivat) to treat children with rare blood disease
Centogene and Takeda extend market access and expansion partnership to advance patient care globally
Sophie Wilford, Qovetia’s Director of Marketing and Communication, launched a webinar addressed to veterinarians